Research Institute of Orlando, LLC

Orlando, Florida 32806-5411

2 studies enrolling now · 8 studies all time

What they study most

Developmental and Epileptic Encephalopathy, Dravet Syndrome, Epilepsy, Focal Epilepsy, Focal Onset Seizures, Primary Generalized Tonic-Clonic Seizures, Tonic-Clonic Seizures

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) — Enrolling by invitation
• A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) — Running, not enrolling
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed